Synthesis of paclitaxel-BGL conjugates

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Pharmacology

Background:

• Paclitaxel is a potent anti-cancer drug.
• Chemical modification of paclitaxel can alter its properties, such as solubility and efficacy.
• Oligoglyceryl modifications offer potential for improved drug delivery.

Purpose of the Study:

• To synthesize novel oligoglyceryl-paclitaxel conjugates.
• To evaluate the anti-tumor activity of these modified paclitaxel compounds.
• To assess the impact of chemical modification on paclitaxel's efficacy.

Main Methods:

• Synthesis of four BGL003-paclitaxel conjugates and one BGL007-paclitaxel conjugate.
• Characterization of synthesized compounds, including molecular weight determination.
• Evaluation of anti-tumor activity for the most water-soluble BGL003 conjugate.

Main Results:

• Successfully synthesized BGL003 and BGL007 paclitaxel conjugates with molecular weights under twice that of paclitaxel.
• The most water-soluble BGL003 conjugate demonstrated preserved anti-tumor activity.
• Chemical modification involved displacement of the N3'-debenzoyl residue with a BGL003 succinyl residue.

Conclusions:

• Oligoglyceryl modification of paclitaxel is feasible.
• The synthesized BGL003-paclitaxel conjugates maintain anti-tumor efficacy.
• Water-soluble paclitaxel derivatives show promise for cancer therapy.